The Market Reports

Synopsis
The global market for Cardiotocograph (CTG) was estimated to be worth US$ 381 million in 2024 and is forecast to a readjusted size of US$ 526 million by 2031 with a CAGR of 4.8% during the forecast period 2025-2031.
This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Cardiotocograph (CTG) cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
Cardiotocography (CTG), also known as Electronic Fetal Monitoring (EFM), which can monitor both the fetal heart rate and uterine contractions. This method provides a paper recording of the fetal heart rate and the uterine contractions, but prevents the mother from leaving the hospital bed and restricts general movement.
The cardiotocograph (CTG) market is being driven by the growing global emphasis on improving maternal and fetal health outcomes. CTG is a vital prenatal monitoring technology used to assess fetal heart rate and uterine contractions during pregnancy and labor, helping healthcare providers detect fetal distress and prevent complications such as hypoxia or stillbirth. The rising global birth rate, especially in developing countries, and increasing awareness of prenatal care are boosting the demand for CTG devices. In developed regions, the adoption of advanced and digital CTG systems is fueled by technological innovations, including wireless monitoring, real-time data integration with electronic medical records, and remote patient monitoring capabilities. These innovations enhance clinical decision-making and workflow efficiency, especially in high-risk pregnancies. Additionally, government initiatives and funding aimed at reducing maternal and infant mortality—such as those led by the WHO and national health programs—are supporting the expansion of prenatal monitoring infrastructure. Private and public investments in modernizing healthcare facilities and the growing number of maternity clinics and hospitals globally also contribute to the market’s positive trajectory.
Despite its benefits, the CTG market faces several challenges that could hinder broader adoption. One of the primary issues is the lack of trained healthcare professionals in many low- and middle-income countries, which limits the effective use and interpretation of CTG data. In these regions, outdated or insufficient monitoring infrastructure further hampers accurate prenatal assessment. Moreover, CTG interpretation can be subjective and prone to variability among clinicians, leading to false positives and unnecessary interventions such as cesarean sections, which raise healthcare costs and risks. There is also a growing debate in the medical community about the overuse of CTG in low-risk pregnancies, with some studies suggesting it does not significantly reduce neonatal morbidity or mortality in such cases. Additionally, the high cost of advanced CTG machines with integrated digital and telemetry functions may be prohibitive for smaller clinics and rural hospitals. Data privacy and integration concerns also arise when using cloud-based or wireless systems, especially in regions with limited digital infrastructure or unclear data protection laws. Addressing these challenges will require not only technological innovation but also investment in training, standardization of interpretation protocols, and equitable access to quality maternal healthcare.
This report aims to provide a comprehensive presentation of the global market for Cardiotocograph (CTG), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Cardiotocograph (CTG) by region & country, by Type, and by Application.
The Cardiotocograph (CTG) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiotocograph (CTG).
Market Segmentation
By Company
GE Healthcare
Philips Healthcare
Edan Instruments
BIOLIGHT
ArjoHuntleigh
Contec Medical Systems
Sunray Medical Apparatus
Bionet
Luckcome
Medgyn Products
BRAEL-Medical Equipment
Medical ECONET
BabyFun
Yuwell
HealForce
Comper
Segment by Type
Traditional CTG
Intelligent CTG
Segment by Application
Hospital
Clinical
Home
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia-Pacific
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (value, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Cardiotocograph (CTG) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Cardiotocograph (CTG) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Cardiotocograph (CTG) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Index